Impact of body mass index (BMI) on endocrine therapy in premenopausal breast cancer patients: An analysis of the ABCSG-12 trial.
Georg Pfeiler(Medical University of Vienna), Michael Gnant(Austrian Breast & Colorectal Cancer Study Group), Christian Marth(Nordic Society of Gynecologic Oncology), Richard Greil(Paracelsus Medical University), M. Seifert, Robert Königsberg(Kaiser-Franz-Josef-Spital), H. Samonigg(Wilhelminen Hospital), Vesna Bjelic‐Radisic(Helios Universitätsklinikum Wuppertal), CF Singer(Innsbruck Medical University), P Dubsky
Cited by 15
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
Breast cancer
|The Lancet|2016|2.3k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k